FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Olivier Déry

Research Profile

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Fabien Schmidlin; Olivier Déry; Nigel W Bunnett; Eileen F Grady
Heterologous regulation of trafficking and signaling of G protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptors.
Olivier Déry; Kathryn DeFea; Nigel W Bunnett
Protein kinase C-mediated desensitization of the neurokinin 1 receptor.
Kathryn DeFea; Z D Vaughn; E M O'Bryan; D Nishijima; Olivier Déry; Nigel W Bunnett
The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Olivier Déry (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Fabien Schmidlin; Olivier Déry; Nigel W Bunnett; Eileen F Grady
Heterologous regulation of trafficking and signaling of G protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptors.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(5):3324-9.
2001: Olivier Déry; Kathryn DeFea; Nigel W Bunnett
Protein kinase C-mediated desensitization of the neurokinin 1 receptor.
American journal of physiology. Cell physiology 2001;280(5):C1097-106.
2000: Kathryn DeFea; Z D Vaughn; E M O'Bryan; D Nishijima; Olivier Déry; Nigel W Bunnett
The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):11086-91.
2000: Kathryn DeFea; J Zalevsky; MS Thoma; Olivier Déry; Dyche R D Mullins; Nigel W Bunnett
beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.
The Journal of cell biology 2000;148(6):1267-81.
2000: Kathryn DeFea; Fabien Schmidlin; Olivier Déry; Eileen F Grady; Nigel W Bunnett
Mechanisms of initiation and termination of signalling by neuropeptide receptors: a comparison with the proteinase-activated receptors.
Biochemical Society transactions 2000;28(4):419-26.
1999: Olivier Déry; MS Thoma; H Wong; Eileen F Grady; Nigel W Bunnett
Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor.
The Journal of biological chemistry 1999;274(26):18524-35.
1999: Carlos U Corvera; Olivier Déry; K McConalogue; P Gamp; MS Thoma; B Al-Ani; George H Caughey; MD Hollenberg; Nigel W Bunnett
Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2.
The Journal of physiology 1999;517 ( Pt 3)():741-56.
1999: K McConalogue; Olivier Déry; M Lovett; H Wong; J H Walsh; Eileen F Grady; Nigel W Bunnett
Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor.
The Journal of biological chemistry 1999;274(23):16257-68.
1999: Olivier Déry; Nigel W Bunnett
Proteinase-activated receptors: a growing family of heptahelical receptors for thrombin, trypsin and tryptase.
Biochemical Society transactions 1999;27(2):246-54.
1998: Olivier Déry; Carlos U Corvera; Martin Steinhoff; Nigel W Bunnett
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.
The American journal of physiology 1998;274(6 Pt 1):C1429-52.
1997: Carlos U Corvera; Olivier Déry; K McConalogue; Stephan Böhm; LM Khitin; George H Caughey; DG Payan; Nigel W Bunnett
Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2.
The Journal of clinical investigation 1997;100(6):1383-93.